Covid-19 Pharma News
PeopleImages.com - Yuri A Shutterstock
COVID-19 infection and some COVID-19 vaccines tied to risk of neurological disorder
A large-scale international study involving researchers from the Drug Safety Research Unit (DSRU), UK, highlights the relationship between SARS-CoV-2 infection, certain COVID-19 vaccines, and Guillain-Barré syndrome (GBS).
9 Jun 2025
Shutterstock
PrecisionLife and Metrodora Institute Partner
PrecisionLife and Metrodora Institute are co-investing in a first-of-its-kind partnership to jumpstart the diagnosis and treatment options for a range of complex, chronic diseases including Long COVID, ME/CFS, ALS, Sjögren's syndrome, and many more.
26 Feb 2024
Shutterstock
Osivax Announce First-in-Human Phase 1 Vaccination Trial
Osivax have announced that the first participant has been vaccinated in its new Phase 1 trial (NCT06128382) evaluating OVX033, a broad-spectrum sarbecovirus vaccine candidate.
15 Feb 2024
Shutterstock
Virios Therapeutics to Develop Long Covid Therapy
Virios Therapeutics, Inc have announced plans for advancing IMC-2 (combination of valacyclovir and celecoxib) as a treatment for the fatigue, orthostatic intolerance and other symptoms associated with long covid.
24 Jan 2024
Shutterstock
African Vaccine Manufacturing Accelerator Make Up $1 Billion To Support Sustainable Vaccine Manufacturing In Africa
The Board of Gavi, the Vaccine Alliance today announced a series of decisions that will help lower-income countries tackle backsliding from the COVID-19 pandemic and be better prepared to respond to future health emergencies.
12 Dec 2023
Shutterstock
WHO Authorise Emergency Use of Novavax Protein-based COVID-19 Vaccine
Novavax Inc have announced that Nuvaxovid XBB.1.5 COVID-19 Vaccine (NVX-CoV2601) has been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) for active immunisation to prevent COVID-19.
28 Nov 2023
Moderna v Pfizer-BioNTech: Lessons to be learnt from post-pandemic disputes
Dr. Nicholas Jones, partner and patent attorney at Withers & Rogers, discusses what the pharma industry can learn from its experiences of working collaboratively during the COVID-19 pandemic by establishing best practice and minimising risks.
13 Sep 2022
Using genomic sequencing to predict COVID’s next move
Brittany Niccum, Beckman Coulter Life Sciences, shares how genomic sequencing and laboratory automation can monitor new variants of COVID and potentially nip them in the bud, before they transform into future pandemics.
17 Aug 2022
Wastewater is anything but a waste: It could even prevent the next pandemic
Ari Goldfarb, CEO, Kando, discusses how innovative technologies and artificial intelligence tools are advancing wastewater analysis and could potentially mitigate the effects, or even prevent, future pandemics.
26 Jul 2022
Sponsored Content
Tjoapack
Tjoapack launches innovative customer dashboard to drive pharma supply chain collaboration
Tjoapack, a global contract packaging organisation, has announced the launch of its Customer Collaboration Dashboard, an innovative digital platform designed to streamline collaboration between Tjoapack and its clients.
Experience. Precision for Advanced Therapy Logistics.
Delivering Temp-Critical Therapy to Korea with Real-Time Monitoring, Cold Chain Control and Life-Saving Precision.
Alex Tao Wang Shutterstock
Shilpa Medicare signs commercial supply deal with Orion
Shilpa Biocare, a fully-owned subsidiary of Shilpa Medicare, announces ahead of BIO Boston that it has secured a Europe-wide commercial supply agreement with Orion Corporation for Recombinant Human Albumin.
16 Jun 2025
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Cytiva
Cytiva completing $1.6 billion in investments
Cytiva, a Danaher company, has completed expansion projects in several locations in the United States, Europe, and Asia.
16 Jun 2025
Pharma Manufacturing News + Pharma Finance and Investment News
Photon photo Shutterstock
Rare disease biotech announces milestone
Oxford-based SynaptixBio, which is developing a therapy for a rare, deadly, and currently incurable rare disease (H-ABC), says it has identified the drug it will take forward into clinical trials.
13 Jun 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
Schneider Electric
Schneider Electric launches new data centre solutions
Schneider Electric, a company in the digital transformation of energy management and automation, has announced new data centre solutions specifically engineered to meet the intensive demands of next-generation AI cluster architectures.
13 Jun 2025
Pharma Manufacturing News + Pharmaceutical Manufacturing News
CKA Shutterstock
RBQM event returns for 2025
CluePoints, the sponsor of RBQMLive and provider of statistical and AI-driven software solutions, has announced the full agenda and expert speaker line up for the 4th annual RBQMLive.
13 Jun 2025
Body Stock Shutterstock
XL-protein grants worldwide license to Grifols
XL-protein has announced that it has entered into a worldwide License, Development and Commercialisation Agreement with Grifols for a long-acting biopharmaceutical product.
12 Jun 2025
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00
Sponsored Content
Tjoapack
Tjoapack launches innovative customer dashboard to drive pharma supply chain collaboration
Tjoapack, a global contract packaging organisation, has announced the launch of its Customer Collaboration Dashboard, an innovative digital platform designed to streamline collaboration between Tjoapack and its clients.
Experience. Precision for Advanced Therapy Logistics.
Delivering Temp-Critical Therapy to Korea with Real-Time Monitoring, Cold Chain Control and Life-Saving Precision.
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00